ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,463, issued on Feb. 24, was assigned to IMPACT BIOMEDICINES INC. (Princeton, N.J.).

"Crystalline forms of a JAK2 inhibitor" was invented by Lianfeng Huang (Basking Ridge, N.J.), Nancy Tsou (Edison, N.J.), Wenju Wu (Warren, N.J.) and Daozhong Zou (Raritan, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides crystalline forms of a JAK2 inhibitor, compositions thereof and methods of treating a JAK2-mediated disorder."

The patent was filed on Feb. 11, 2020, under Application No. 17/430,188.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&S...